• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

临床义务和公共卫生计划:医疗保健提供者关于管理新生儿筛查偶然结果的推理。

Clinical obligations and public health programmes: healthcare provider reasoning about managing the incidental results of newborn screening.

机构信息

Department of Health Policy, Management and Evaluation, University of Toronto, Ontario, Canada.

出版信息

J Med Ethics. 2009 Oct;35(10):626-34. doi: 10.1136/jme.2009.030346.

DOI:10.1136/jme.2009.030346
PMID:19793944
Abstract

BACKGROUND

Expanded newborn screening generates incidental results, notably carrier results. Yet newborn screening programmes typically restrict parental choice regarding receipt of this non-health serving genetic information. Healthcare providers play a key role in educating families or caring for screened infants and have strong beliefs about the management of incidental results.

METHODS

To inform policy on disclosure of infant sickle cell disorder (SCD) carrier results, a mixed-methods study of healthcare providers was conducted in Ontario, Canada, to understand attitudes regarding result management using a cross-sectional survey (N = 1615) and semistructured interviews (N = 42).

RESULTS

Agreement to reasons favouring disclosure of SCD carrier results was high (65.1%-92.7%) and to reasons opposing disclosure was low (4.1%-18.1%). Genetics professionals expressed less support for arguments favouring disclosure (35.3%-78.8%), and more agreement with arguments opposing disclosure (15.7%-51.9%). A slim majority of genetics professionals (51.9%) agreed that a reason to avoid disclosure was the importance of allowing the child to decide to receive results. Qualitatively, there was a perceived "duty" to disclose, that if the clinician possessed the information, the clinician could not withhold it.

DISCUSSION

While a majority of respondents perceived a duty to disclose the incidental results of newborn screening, the policy implications of these attitudes are not obvious. In particular, policy must balance descriptive ethics (ie, what providers believe) and normative ethics (ie, what duty-based principles oblige), address dissenting opinion and consider the relevance of moral principles grounded in clinical obligations for public health initiatives.

摘要

背景

扩展新生儿筛查会产生偶然结果,尤其是携带者结果。然而,新生儿筛查计划通常限制了父母对接受这种非健康相关遗传信息的选择。医疗保健提供者在教育家庭或照顾接受筛查的婴儿方面发挥着关键作用,并且对偶然结果的管理有强烈的信念。

方法

为了为婴儿镰状细胞病(SCD)携带者结果的披露政策提供信息,在加拿大安大略省进行了一项针对医疗保健提供者的混合方法研究,以使用横断面调查(N=1615)和半结构化访谈(N=42)了解对结果管理的态度。

结果

对支持披露 SCD 携带者结果的理由的一致性很高(65.1%-92.7%),而对反对披露的理由的一致性很低(4.1%-18.1%)。遗传专业人员对支持披露的论点表示的支持较少(35.3%-78.8%),而对反对披露的论点表示的同意较多(15.7%-51.9%)。只有少数遗传专业人员(51.9%)同意避免披露的一个原因是允许孩子决定是否接受结果的重要性。从定性上看,有一种“责任”来披露,即如果临床医生掌握了信息,就不能隐瞒它。

讨论

尽管大多数受访者认为有责任披露新生儿筛查的偶然结果,但这些态度的政策影响并不明显。特别是,政策必须平衡描述性伦理(即提供者的信念)和规范性伦理(即基于义务的原则所要求的义务),解决不同意见,并考虑基于临床义务的道德原则对公共卫生倡议的相关性。

相似文献

1
Clinical obligations and public health programmes: healthcare provider reasoning about managing the incidental results of newborn screening.临床义务和公共卫生计划:医疗保健提供者关于管理新生儿筛查偶然结果的推理。
J Med Ethics. 2009 Oct;35(10):626-34. doi: 10.1136/jme.2009.030346.
2
Consent for newborn screening: the attitudes of health care providers.新生儿筛查的同意书:医疗服务提供者的态度
Public Health Genomics. 2010;13(3):181-90. doi: 10.1159/000240966. Epub 2009 Sep 22.
3
Newborn screening for sickle cell disease in a Nigerian hospital.尼日利亚一家医院对镰状细胞病的新生儿筛查。
Public Health. 2008 Oct;122(10):1111-6. doi: 10.1016/j.puhe.2008.01.008. Epub 2008 May 19.
4
Genetic Counselors' Experience with and Opinions on the Management of Newborn Screening Incidental Carrier Findings.遗传咨询师对新生儿筛查意外携带者结果管理的经验与看法。
J Genet Couns. 2018 Dec;27(6):1328-1340. doi: 10.1007/s10897-018-0258-0. Epub 2018 Apr 23.
5
American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.美国临床肿瘤学会政策声明更新:癌症易感性基因检测
J Clin Oncol. 2003 Jun 15;21(12):2397-406. doi: 10.1200/JCO.2003.03.189. Epub 2003 Apr 11.
6
Informing parents about expanded newborn screening: influences on provider involvement.向家长告知扩大的新生儿筛查:对提供者参与的影响。
Pediatrics. 2009 Sep;124(3):950-8. doi: 10.1542/peds.2008-3148. Epub 2009 Aug 10.
7
A pilot study to evaluate knowledge and attitudes of Illinois pediatricians toward newborn screening for sickle cell disease and cystic fibrosis.一项评估伊利诺伊州儿科医生对新生儿镰状细胞病和囊性纤维化筛查知识和态度的初步研究。
Am J Perinatol. 2011 Mar;28(3):169-76. doi: 10.1055/s-0030-1265828. Epub 2010 Sep 9.
8
Recommendations for effective newborn screening communication: results of focus groups with parents, providers, and experts.有效新生儿筛查沟通的建议:与家长、医护人员及专家的焦点小组讨论结果
Pediatrics. 2006 May;117(5 Pt 2):S326-40. doi: 10.1542/peds.2005-2633M.
9
Neonatal screening for treatable and untreatable disorders: prospective parents' opinions.新生儿可治疗和不可治疗疾病的筛查:准父母的意见。
Pediatrics. 2010 Jan;125(1):e99-106. doi: 10.1542/peds.2009-0269. Epub 2009 Dec 21.
10
Dental screening and referral of young children by pediatric primary care providers.儿科初级保健提供者对幼儿进行牙科筛查和转诊。
Pediatrics. 2004 Nov;114(5):e642-52. doi: 10.1542/peds.2004-1269.

引用本文的文献

1
Health services use by children identified as heterozygous hemoglobinopathy mutation carriers via newborn screening.通过新生儿筛查发现的杂合子血红蛋白病突变携带者的儿童健康服务利用情况。
BMC Pediatr. 2021 Jul 1;21(1):296. doi: 10.1186/s12887-021-02751-8.
2
Simple Test, Complex System: Multifaceted Views of Newborn Screening Science, Technology, and Policy.简单测试,复杂系统:新生儿筛查科学、技术与政策的多面视角
Glob Pediatr Health. 2019 Dec 20;6:2333794X19894812. doi: 10.1177/2333794X19894812. eCollection 2019.
3
Genetic Counselors' Experience with and Opinions on the Management of Newborn Screening Incidental Carrier Findings.
遗传咨询师对新生儿筛查意外携带者结果管理的经验与看法。
J Genet Couns. 2018 Dec;27(6):1328-1340. doi: 10.1007/s10897-018-0258-0. Epub 2018 Apr 23.
4
Guidelines on neonatal screening and painful vaso-occlusive crisis in sickle cell disease: Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular: Project guidelines: Associação Médica Brasileira - 2016.镰状细胞病新生儿筛查与疼痛性血管闭塞危象指南:巴西血液学、血液治疗与细胞治疗协会:项目指南:巴西医学协会 - 2016年
Rev Bras Hematol Hemoter. 2016 Apr-Jun;38(2):147-57. doi: 10.1016/j.bjhh.2016.04.001. Epub 2016 Apr 8.
5
Parental Views on Expanded Newborn Screening Using Whole-Genome Sequencing.父母对使用全基因组测序进行扩大新生儿筛查的看法。
Pediatrics. 2016 Jan;137 Suppl 1(Suppl 1):S36-46. doi: 10.1542/peds.2015-3731H.
6
Primary care role in expanded newborn screening: After the heel prick test.初级保健在扩大新生儿筛查中的作用:足跟采血试验后。
Can Fam Physician. 2013 Aug;59(8):861-8.
7
Reflecting on earlier experiences with unsolicited findings: points to consider for next-generation sequencing and informed consent in diagnostics.反思早期在非预期发现方面的经验:下一代测序和诊断知情同意中的注意要点。
Hum Mutat. 2013 Oct;34(10):1322-8. doi: 10.1002/humu.22370. Epub 2013 Jul 16.
8
Incidental findings from clinical genome-wide sequencing: a review.临床全基因组测序的偶然发现:综述
J Genet Couns. 2014 Aug;23(4):463-73. doi: 10.1007/s10897-013-9604-4. Epub 2013 May 26.
9
Effort required to contact primary care providers after newborn screening identifies sickle cell trait.新生儿筛查发现镰状细胞特征后,与初级保健提供者联系所需的努力。
J Natl Med Assoc. 2012 Nov-Dec;104(11-12):528-34. doi: 10.1016/s0027-9684(15)30219-4.
10
To tell or not to tell? A systematic review of ethical reflections on incidental findings arising in genetics contexts.是否告知?遗传学背景下偶然发现的伦理思考系统综述。
Eur J Hum Genet. 2013 Mar;21(3):248-55. doi: 10.1038/ejhg.2012.130. Epub 2012 Jun 27.